Wordt geladen...
Critical appraisal of sorafenib in the treatment of Chinese patients with renal cell carcinoma
Renal cell carcinoma (RCC) accounts for 3% of all malignancies, and is the most aggressive cancer of the genitourinary system. Metastatic RCC is naturally resistant to chemotherapy and radiotherapy, and immunotherapy is of little benefit. In recent years, the emergence of molecular-targeted therapie...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4057324/ https://ncbi.nlm.nih.gov/pubmed/24944516 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S41828 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|